Laws, Regulations & Activism
WHAT’S NEW
Psychedelic Science 2025: Set and (Re)Setting
For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and...
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
POPULAR ARTICLES
Breaking: Colorado Becomes the 2nd State to Decriminalize Psychedelics
In a tight race that came down the wire, Colorado voters approve Measure 122 to decriminalize small amounts of psychedelic drugs...
Read More
Study Finds That Ayahuasca Could Make You Less Narcissistic
Narcissists can take a hike. Or maybe a trip....
Read More
New Poll Shows 61% of Americans Support Legalizing Psychedelic Therapy
The poll from the University of California, Berkeley is the first of its kind....
Read More
Funding the Future of Psychedelic Medicine in Europe: An Interview with Norrsken Mind
Psychedelic Alpha’s Josh Hardman sits down with Emma Christersson and Marcus Stråth, the co-managing directors of Norrs...
Read More
6 facts about psychedelic drugs that will totally blow your mind
Despite the fact that the U.S. government deems many hallucinogenic or psychedelic substances to be dangerous, classifying them as...
Read More
Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction Recovery
Ibogaine’s anti-addictive properties are known to work wonders on people struggling with various substances, such as cocaine...
Read More